Yoldas et al. revealed that TRAIL and DR4 expression were correlated with the pathological grading in patients with laryngeal squamous cell carcinoma, while the alteration in DR5 expression was correlated with the clinical staging [50]. The gene discussed is TNFRSF10A; the disease is laryngeal squamous cell carcinoma.